These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 19557734

  • 1. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
    Yu JS, Kim JH, Chung JJ, Kim KW.
    J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
    [Abstract] [Full Text] [Related]

  • 2. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    J Magn Reson Imaging; 2008 Apr; 27(4):834-9. PubMed ID: 18383261
    [Abstract] [Full Text] [Related]

  • 3. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ, Zhang L, Ouyang YS.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 16; 88(35):2474-7. PubMed ID: 19080627
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.
    Chung J, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW.
    Magn Reson Imaging; 2011 Nov 16; 29(9):1235-43. PubMed ID: 21907517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov 16; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

  • 12. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.
    Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B.
    Eur J Radiol; 2013 Apr 16; 82(4):577-82. PubMed ID: 23246330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.
    Kim S, Mannelli L, Hajdu CH, Babb JS, Clark TW, Hecht EM, Taouli B.
    J Magn Reson Imaging; 2010 Feb 16; 31(2):348-55. PubMed ID: 20099348
    [Abstract] [Full Text] [Related]

  • 15. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?
    Zhao XT, Li WX, Chai WM, Chen KM.
    J Dig Dis; 2014 Mar 16; 15(3):137-45. PubMed ID: 24354621
    [Abstract] [Full Text] [Related]

  • 16. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
    Liu R, Wang JH, Zhou KR, Yan FH, Yan ZP, Shen JZ, Tan YS, Cai Y.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct 16; 13(10):754-8. PubMed ID: 16248948
    [Abstract] [Full Text] [Related]

  • 17. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC.
    J Magn Reson Imaging; 2004 May 16; 19(5):598-604. PubMed ID: 15112309
    [Abstract] [Full Text] [Related]

  • 18. [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
    Xiao YP, Xiao EH, Luo JG, Bian DJ, Li MQ, He Z, Shang QL, Liang B.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 16; 30(12):914-6. PubMed ID: 19173992
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec 16; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 20. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
    Park HJ, Kim SH, Jang KM, Lim S, Kang TW, Park HC, Choi D.
    AJR Am J Roentgenol; 2014 Jan 16; 202(1):92-101. PubMed ID: 24370133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.